Effect of Hypnotherapy in Irritable Bowel Syndrome (IBS)

This study has been completed.
Sponsor:
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01279382
First received: January 17, 2011
Last updated: January 18, 2011
Last verified: January 2011

January 17, 2011
January 18, 2011
January 2002
Not Provided
Mean symptom score (MSS)
Same as current
Complete list of historical versions of study NCT01279382 on ClinicalTrials.gov Archive Site
Psychological measures, i.e. anxiety and depression (HADS)
Same as current
Not Provided
Not Provided
 
Effect of Hypnotherapy in Irritable Bowel Syndrome (IBS)
Effectiviteit Van Hypnotherapie Bij Prikkelbare Darmsyndroom (Effectiveness of Hypnotherapy in Irritable Bowel Syndrome)

In this trial, the effects of two psychological interventions - i.e. hypnotherapy and relaxation training - are compared with care as usual in IBS treatment. The investigators hypothesized that hypnotherapy is most effective in reducing complaints in IBS.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Irritable Bowel Syndrome
  • Behavioral: Hypnotherapy (HYP)
    Hypnotherapy was given to a subgroup of patients as intervention in IBS treatment
  • Behavioral: Relaxation training (RT)
    RT was given to a subgroup of patients as intervention in IBS treatment
  • Other: Care as usual (CON)
    CON was given to a subgroup of patients as control intervention in IBS treatment
  • Care as usual (CON)
    CON was given to a subgroup of patients as control treatment in IBS treatment
    Intervention: Other: Care as usual (CON)
  • Hypnotherapy (HYP)
    HYP was given to a subgroup of patients as intervention in IBS treatment
    Intervention: Behavioral: Hypnotherapy (HYP)
  • Relaxation training (RT)
    RT was given to a subgroup of patients as intervention in IBS treatment
    Intervention: Behavioral: Relaxation training (RT)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
112
January 2006
Not Provided

Inclusion Criteria:

  • Irritable bowel syndrome (Rome II)
  • Presence of complaints < 12 months

Exclusion Criteria:

  • Gastrointestinal disorders, other than IBS
  • Previous psychotherapeutic treatment for IBS
  • Severe psychological comorbidity
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT01279382
P113/99
Yes
Prof. Dr. A. Masclee, Maastricht University Medical Center
Maastricht University Medical Center
Not Provided
Principal Investigator: Ad Masclee, Prof. Dr. Head of dept
Maastricht University Medical Center
January 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP